The U.S. Food and Drug Administration (FDA) has initiated a crackdown on marijuana product manufacturers for claiming their products can be effective as a treatment for cancer, Alzheimer’s and other conditions. The FDA claims companies are “illegally selling products online that claim to prevent, diagnose, treat or cure cancer without evidence to support these outcomes.” As a result, they have issued warnings to 4 companies: Stanley Brothers Social Enterprises, Green Roads of Florida, That’s Natural and Natural Alchemist. Each of these companies manufactures products that contain the marijuana compound cannabidiol (CBD) and make health claims on the packaging that are based on the medicinal aspects of the compound that is often recommended by doctors for a variety of conditions, including cancer and Alzheimer’s.
“We’re Not Going to Look the Other Way”
FDA Commissioner Scott Gottlieb said in a press release that “substances that contain components of marijuana will be treated like any other products that make unproven claims to shrink cancer tumors. We don’t let companies market products that deliberately prey on sick people with baseless claims that their substance can shrink or cure cancer and we’re not going to look the other way on enforcing these principles when it comes to marijuana-containing products.”
A Blockade Against Federal Research
The Drug Enforcement Administration (DEA) have classed marijuana as a Schedule I drug alongside heroin and LSD. Schedule I drugs are considered to be the highest risk drugs, having no medicinal benefits, highly addictive and unsafe for testing on humans. As a result, all medical testing on the plant has been banned in any official capacity. This makes all non-governmental medical research on the plant unusable for official purposes and makes it impossible to prove or disprove the plant’s medicinal benefits for official government purposes. The DEA decided to start allowing scientists to apply to conduct medical research on the plant but the Department of Justice, headed by long time, vocal prohibitionist Jeff Sessions, has prevented any forward movement on approving any of these applications. Therefore, marijuana remains a Schedule I drug with the immense amount of research proving the plants medicinal benefits blocked for use by the government, including the FDA and DEA.
Research Into Medical Benefits of Marijuana
Nonetheless, there is an abundance of research that has been conducted all over the world proving that marijuana does have the ability to shrink tumors and cure cancer as well as treat and even reverse the symptoms of Alzheimer’s. There are countless studies that show the medicinal benefits of cannabis including ones that show it can shrink some tumors including the most aggressive brain tumors as well as stopping it from spreading through the body. These have been conducted by leading scientists at St. George’s University of London and Vanderbilt University School of Medicine, Nashville as well as other prestigious medical laboratories.
Despite attempts by officials to block the release of evidence that would reveal marijuana’s medicinal benefits, 29 states and Washington D.C. have legalized marijuana for medicinal purposes and 8 states as well as D.C. have legalized the plant for personal recreational use as it has been found to be healthier and safer than both cigarettes and alcohol and therefore regulated in this way by those states. As education about the many medical benefits of marijuana are discovered and released in popular medical journeys, more people are finding their own truth about the plant. The last Gallup poll indicated that 64 percent of the country are in favor of legalizing the plant for personal use and a recent Yahoo/Marist poll conducted earlier this year indicated that 83 percent of the nation are in favor of legalizing the plant for medical use.